These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

167 related articles for article (PubMed ID: 10971374)

  • 21. Terbinafine is more effective than itraconazole in treating toenail onychomycosis: results from a meta-analysis of randomized controlled trials.
    Krob AH; Fleischer AB; D'Agostino R; Feldman SR
    J Cutan Med Surg; 2003; 7(4):306-11. PubMed ID: 14738099
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Safety of oral terbinafine for toenail onychomycosis.
    Pollak R; Billstein SA
    J Am Podiatr Med Assoc; 1997 Dec; 87(12):565-70. PubMed ID: 9425805
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Single-blind, randomized, prospective study of sequential itraconazole and terbinafine pulse compared with terbinafine pulse for the treatment of toenail onychomycosis.
    Gupta AK; Lynde CW; Konnikov N
    J Am Acad Dermatol; 2001 Mar; 44(3):485-91. PubMed ID: 11209119
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Terbinafine, a unique oral antifungal: current perceptions.
    Jain S; Sehgal VN
    Int J Dermatol; 2000 Jun; 39(6):412-23. PubMed ID: 10944085
    [No Abstract]   [Full Text] [Related]  

  • 25. Long-term results in patients with onychomycosis treated with terbinafine or itraconazole.
    Heikkilä H; Stubb S
    Br J Dermatol; 2002 Feb; 146(2):250-3. PubMed ID: 11903235
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Treatment of toenail onychomycosis. Prescribing terbinafine to every patient with the condition would be expensive.
    Rose P; Wilson T
    BMJ; 1999 Oct; 319(7218):1197. PubMed ID: 10610152
    [No Abstract]   [Full Text] [Related]  

  • 27. The impact of aggressive debridement used as an adjunct therapy with terbinafine on perceptions of patients undergoing treatment for toenail onychomycosis.
    Potter LP; Mathias SD; Raut M; Kianifard F; Landsman A; Tavakkol A
    J Dermatolog Treat; 2007; 18(1):46-52. PubMed ID: 17373090
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Satisfaction with onychomycosis treatment. Pulse versus continuous dosing.
    Warshaw EM; Bowman T; Bodman MA; Kim JJ; Silva S; Mathias SD
    J Am Podiatr Med Assoc; 2003; 93(5):373-9. PubMed ID: 13130084
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Efficacy of itraconazole, terbinafine, fluconazole, griseofulvin and ketoconazole in the treatment of Scopulariopsis brevicaulis causing onychomycosis of the toes.
    Gupta AK; Gregurek-Novak T
    Dermatology; 2001; 202(3):235-8. PubMed ID: 11385230
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Randomised double blind comparison of terbinafine and itraconazole for treatment of toenail tinea infection. Seventh Lamisil German Onychomycosis Study Group.
    Bräutigam M; Nolting S; Schopf RE; Weidinger G
    BMJ; 1995 Oct; 311(7010):919-22. PubMed ID: 7580551
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Terbinafine vs. placebo for onychomycosis in black patients.
    Billstein S; Kianifard F; Justice A
    Int J Dermatol; 1999 May; 38(5):377-9. PubMed ID: 10369551
    [No Abstract]   [Full Text] [Related]  

  • 32. Terbinafine and onychomycosis.
    Eastcott DF
    N Z Med J; 1991 Jan; 104(904):17. PubMed ID: 1826145
    [No Abstract]   [Full Text] [Related]  

  • 33. Single-blind, randomized, prospective study on terbinafine and itraconazole for treatment of dermatophyte toenail onychomycosis in the elderly.
    Gupta AK; Konnikov N; Lynde CW
    J Am Acad Dermatol; 2001 Mar; 44(3):479-84. PubMed ID: 11209118
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Safety and efficacy of oral terbinafine in the treatment of onychomycosis: analysis of the elderly subgroup in Improving Results in ONychomycosis-Concomitant Lamisil and Debridement (IRON-CLAD), an open-label, randomized trial.
    Tavakkol A; Fellman S; Kianifard F
    Am J Geriatr Pharmacother; 2006 Mar; 4(1):1-13. PubMed ID: 16730616
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Onychomycosis: treatment perspective.
    Jain S; Sehgal VN
    Int J Dermatol; 2000 Jan; 39(1):10-4. PubMed ID: 10651956
    [No Abstract]   [Full Text] [Related]  

  • 36. A randomized treatment duration-finding study of terbinafine in onychomycosis.
    van der Schroeff JG; Cirkel PK; Crijns MB; Van Dijk TJ; Govaert FJ; Groeneweg DA; Tazelaar DJ; De Wit RF; Wuite J
    Br J Dermatol; 1992 Feb; 126 Suppl 39():36-9. PubMed ID: 1531927
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Clinical trials of the new antifungal drug therapies.
    Rand S
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):863. PubMed ID: 8632094
    [No Abstract]   [Full Text] [Related]  

  • 38. An open comparative study of nail drilling as adjunctive treatment for toenail onychomycosis (.).
    Shemer A; Gupta AK; Amichai B; Farhi R; Baran R; Daniel CR; Daigle D; Foley KA
    J Dermatolog Treat; 2016 Oct; 27(5):480-3. PubMed ID: 27032812
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Short-duration therapy with terbinafine for dermatophyte onychomycosis: a multicentre trial.
    Goodfield MJ
    Br J Dermatol; 1992 Feb; 126 Suppl 39():33-5. PubMed ID: 1531926
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Diagnosis and treatment of onychomycoses with terbinafine (Lamisil)].
    Baudraz F; Rakosi T
    Rev Med Suisse Romande; 1998 Nov; 118(11):975-9. PubMed ID: 9865129
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.